InterCure Ltd. (TLV:INCR)
Israel
· Delayed Price · Currency is ILS · Price in ILA 527.30
-14.00 (-2.59%)
Jun 5, 2025, 5:24 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 250.58 million as of June 6, 2025. Its market cap has decreased by -50.69% in one year.
Market Cap
250.58M
Enterprise Value
384.03M
Revenue
238.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
527.30
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 250.58M, an increase of 3,809.91%. That is a compound annual growth rate of 28.81%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 69.03B |
| Danel (Adir Yeoshua) | 2.44B |
| Kamada | 1.34B |
| Bait Bakfar | 1.15B |
| SofWave Medical | 754.78M |
| Novolog (Pharm-Up 1966) | 710.07M |
| BrainsWay | 708.18M |
| Ilex Medical | 685.16M |